SARAH HEARN: Open Payments
NPI 1043283575 · ORANGEBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 34 payments from 11 companies in 2025. Trend: 2023 $585 · 2024 $788 · 2025 $817
Food & beverage: $712Education: $105
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 9 | $264 |
| Astellas Pharma US Inc | 6 | $153 |
| MILLICENT US INC | 4 | $106 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $80 |
| SHIELD THERAPEUTICS INC | 2 | $42 |
| Exeltis, USA Inc. | 2 | $39 |
| Novo Nordisk Inc | 1 | $32 |
| Organon LLC | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Minerva Surgical, Inc | 1 | $22 |
Products named: ZURZUVAE, Veozah, INTRAROSA, ACCRUFER, SLYND, Wegovy, NEXPLANON, INJECTAFER.
Industry payments across SC — which companies pay providers there.
